The Analysis of Muscle Relaxants by Mass Spectrometric Methods

[1]  S. Ágoston.  Paralysis after long-term administration of vecuronium. , 1991, Anesthesiology.

[2]  R. Miller,et al.  Prolonged neuromuscular blockade after long-term administration of vecuronium in two critically ill patients. , 1990, Anesthesiology.

[3]  T. Baker,et al.  Mass spectrometry of various neuromuscular blocking agents , 1990 .

[4]  T. Baker,et al.  Mass spectrometric assay for determination of pancuronium and vecuronium in biological fluids utilizing the moving belt introduction system. , 1990, Biomedical & environmental mass spectrometry.

[5]  R. Annan,et al.  Measurement of D-tubocurarine chloride in human urine using solid-phase extraction and reversed-phase high-performance liquid chromatography with ultraviolet detection. , 1990, Journal of chromatography.

[6]  T. Baker,et al.  Mass spectrometry of pancuronium bromide and related quaternary ammonium steroids using the moving belt LC/MS interface , 1989 .

[7]  Alfonso Martinez Arias,et al.  Molecular biology of the cell (2nd edn): edited by B. Alberts, D. Bray, J. Lewis, M. Raff, K. Roberts and J.D, Watson, Garland, 1989 $46.95 (v + 1187 pages) ISBN 0 8240 3695 6 , 1989 .

[8]  R. Miller,et al.  Quantitation of pancuronium, 3-desacetylpancuronium, vecuronium, 3-desacetylvecuronium, pipecuronium and 3-desacetylpipecuronium in biological fluids by capillary gas chromatography using nitrogen-sensitive detection. , 1988, Journal of chromatography.

[9]  W. Young,et al.  The Effect of Phenytoin on the Magnitude and Duration of Neuromuscular Block Following Atracurium or Vecuronium , 1987, Anesthesiology.

[10]  Z. Ebrahim,et al.  Resistance to pancuronium in patients receiving carbamazepine. , 1987, Anesthesiology.

[11]  N. Goudsouzian,et al.  Clinical Pharmacology of Muscle Relaxants in Patients With Burns , 1986, Journal of clinical pharmacology.

[12]  R. Miller,et al.  Quantitative estimation of quaternary ammonium neuromuscular blocking agents in serum by direct insertion probe chemical ionization mass spectrometry. , 1986, Biomedical & environmental mass spectrometry.

[13]  G. Gronert.  Resistance to pancuronium. , 1986, Anesthesia and analgesia.

[14]  R. Miller,et al.  Clinical Pharmacology of Vecuronium and Atracurium , 1984, Anesthesiology.

[15]  J. E. Paanakker,et al.  Determination of Org NC 45 (a myoneural blocking agent) in human plasma using high-performance normal-phase liquid chromatography. , 1980, Journal of chromatography.

[16]  R. Miller,et al.  The comparative potency and pharmacokinetics of pancuronium and its metabolites in anesthetized man. , 1978, The Journal of pharmacology and experimental therapeutics.

[17]  R. Kinget,et al.  Thin-layer chromatography of pancuronium bromide and its hydrolkysis products , 1976 .

[18]  J. McCloskey,et al.  Chemical ionization mass spectrometry of nucleosides. Mechanisms of ion formation and estimations of proton affinity. , 1975, Journal of the American Chemical Society.

[19]  K. Tanaka,et al.  Determination of pancuronium bromide and its metabolites in human urine by dye-extraction method--relation between the extractability and structure of quaternary ammonium ions. , 1974, Chemical & pharmaceutical bulletin.

[20]  W. Buzello.  [The colorimetric determination of pancuronium and its desacetyl derivatives in the human body fluids (author's transl)]. , 1974, Der Anaesthesist.

[21]  R. Weinkam.  Importance of intramolecular associations in the chemical ionization mass spectra of monoenoic and monoepoxy fatty acid methyl esters , 1974 .

[22]  G. Milne,et al.  Chemical ionization mass spectrometry of complex molecules. XI. Stereochemical and conformational effects in the isobutane chemical ionization mass spectra of some steroidal amino alcohols. , 1973, Journal of the American Chemical Society.

[23]  S. Spector,et al.  Determination of serum d-tubocurarine concentration by radioimmunoassay. , 1973, The Journal of pharmacology and experimental therapeutics.

[24]  D. Meijer,et al.  Fluorimetric and chromatographic determination of pancuronium bromide and its metabolites in biological materials. , 1973, Clinica chimica acta; international journal of clinical chemistry.

[25]  J. McCloskey,et al.  Influence of remote functional groups in the chemical ionization mass spectra of long-chain compounds , 1971 .

[26]  J. McCloskey,et al.  Chemical ionization mass spectrometry of nucleosides. , 1971, Biochimica et biophysica acta.

[27]  G. Milne,et al.  Chemical ionization mass spectrometry of complex molecules. , 1969, Journal of the American Chemical Society.

[28]  C. Marjoribanks,et al.  The pharmacology of pancuronium bromide (Org.NA97), a new potent steroidal neuromuscular blocking agent. , 1968, British journal of pharmacology and chemotherapy.

[29]  A. M. Reid,et al.  The neuromuscular blocking properties of a new steroid compound, pancuronium bromide. A pilot study in man. , 1967, British journal of anaesthesia.

[30]  Johnson,et al.  THE USE OF CURARE IN GENERAL ANESTHESIA , 1942 .

[31]  L. Goodman,et al.  THE PHARMACOLOGICAL BASIS OF THERAPEUTICS , 1966 .